Skip to main content

Conference Correspondent

Conference Correspondent

Corticosteroid Use Reduced across 52 Weeks of Belimumab Therapy in Patients with Lupus: Combined Analyses from the BLISS Trials

Conference Correspondent

Belimumab Shows Clinical Response and Sustained Reductions in Circulating B Cells and in IgG Levels in Patients with Lupus

Conference Correspondent

Postmarketing Experience with Belimumab in Patients with Lupus in Clinical Practice Settings Confirms the Evidence from Clinical Trials

Conference Correspondent

High Levels of Interferon Type I in Plasma of Patients with Lupus Predict Future Renal Disease

Conference Correspondent

Biomarkers that Predict Development or Worsening of Lupus Nephritis in Patients with Systemic Lupus Erythematosus

Conference Correspondent

Can MDHAQ/RAPID3 Be Used in Usual Care of Patients with Systemic Lupus Erythematosus?

Conference Correspondent

Exploring a Novel Therapeutic Target in a Murine Model of Systemic Lupus Erythematosus: Targeting Sphingosine-1-Phosphate Receptors

Conference Correspondent

Serious Infections among Patients with Lupus Who Receive Corticosteroids and Immunosuppressants

Conference Correspondent

Adding Abatacept to the Euro-Lupus Nepthritis Regimen in Patients with Lupus Nephritis: Results from ACCESS, a 24-Week, Double-Blind Controlled Trial

Conference Correspondent

Association of Psoriasis and Psoriatic Arthritis with Lupus

5
6
7
8

Page 8 of 8
Results 71 - 80 of 80